Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 248 results for "sun pharma advanced research"

Premature to talk of changes in Ranbaxy management team now
Business Standard India

Sun Pharma makes open offer for Zenotech stake

Related to : Sun Pharma Advanced Research Company Ltd,Sun Pharmaceuticals Industries Ltd Sun Pharma Advanced Research Company Ltd BSE 11 Apr 14 | 12:00 AM 155.50 -2.6 (-1.64%) NSE 11 Apr 14 | 12:00 AM 155.60 -2.25 (-1.43%) Sun ... Smart Investor, 1 week ago
Premature to talk of changes in Ranbaxy management team now Business Standard India, 6 days ago

58 images for sun pharma advanced research

Rediff.com, 5 days ago
XinMsn, 1 week ago
Health Canal, 6 days ago
South Florida Sun-Sentinel, 1 week ago
Bioscience Technology Online, 5 days ago
KFGO News, 1 week ago
Yahoo! Finance, 1 week ago
Reuters, 1 week ago
Yahoo! News, 1 week ago
Reuters, 1 week ago

Sun Pharma Advanced Research (₹156.7): BUY

Investors with a short-term perspective can buy the stock of Sun Pharma Advanced Research Company at current levels. The stock has been on an intermediate-term uptrend since taking support at 105 in August 2013. Following a corrective downtrend, the stock ...
 Business Line1 week ago Buy Sun Pharma Advanced Research Co with target price of Rs 190: Mitesh Thacker  Economic Times1 month ago

SPARC announces India approval for PICN

Sun Pharma Advanced Research Company (SPARC) has announced that its licensee has received an approval from the Drug Controller General of India for Paclitaxel Injection Concentrate for Nanodispersion (PICN), indicated for the treatment of metastatic breast ...
 Myiris2 months ago SPARC gets India approval for Paclitaxel Injection Concentrate for Nanodispersion  Money Control2 months ago

Sun Pharma gets DGCI nod for breast cancer drug

Sun Pharma Advanced Research Company today said it has received the approval of the Drug Controller General of India (DGCI) for its medicine for treatment of breast cancer. The medicine, Paclitaxel Injection Concentrate for Nanodispersion (PICN), was found to ...
 Business Standard2 months ago SPARC gains on getting DGCI nod for breast cancer drug  Business Standard2 months ago
Money Control

Stocks in news: Ranbaxy, SPARC, LT Fin, Cairn, Novartis

Ranbaxy Labs | Sesa Sterlite | Hindustan Zinc | MBL Infra | Mastek | GMR Infrastructure | Sun Pharma Advanced Research Company | LT Finance Holdings | Novartis | Cairn India | Triveni Turbine | Zee Media and Parrys Sugar are stocks, which are in the news ...
 Money Control2 months ago

Pharmacovigilance and Related Developments: Industry and Market Analysis 2014-2024

LONDON , April 16, 2014 /PRNewswire/ -- Post-marketing surveillance for medicines - discover trends, outlooks, and revenues Where are pharmacovigilance and related needs heading? For those pharmaceutical testing studies you get new analysis, also ...
 Sys-Con Italia4 days ago

Research and Markets Adds Report: Glaucoma - Pipeline Review, H1 2014

Research and Markets has announced the addition of the "Glaucoma - Pipeline Review, H1 2014" report to its offerings. In a release, Research and Markets noted that report highlights include: This report provides comprehensive information on the ...
 Individual.com1 week ago Global Glaucoma Pipeline Review, H1 2014  Individual.com1 week ago Research and Markets: Global Glaucoma Pipeline Review, H1 2014  TMC Net1 week ago RESEARCH AND MARKETS : Global Glaucoma Pipeline Review, H1 2014  4 Traders1 week ago
[x]  
NDTV Profit

Sensex falls 86 points,Infosys advances 1% ahead of Q4 results

3:42 p.m. Sensex ends 86 points lower at 22,628, Infosys gains 1% ahead of Q4 results on Tuesday 3:31 p.m. Sensex ends 104 points lower to 22,610 (provisional), Nifty closes at 6,776 2:45 p.m. Markets recover in late trade with Sensex ...
 NDTV Profit1 week ago Sensex falls 173 points on profit taking, Ukraine crisis  NDTV Profit1 month ago Sensex falls 173 points on profit-taking, Ukraine crisis  NDTV Profit1 month ago

Ranbaxy deal to push Sun Pharmaceutical's global growth

NEW YORK — Sun Pharmaceutical Industries, India's largest drug maker by market value, agreed to buy competitor Ranbaxy Laboratories for $3.2bn in stock to bolster sales in faster-growing emerging markets. Ranbaxy investors will get 0.8 of a share ...
 BDlive1 week ago India's Sun Pharma to Acquire Ranbaxy in $4 Billion Transaction  Washington Post1 week ago India's Sun Pharma to Buy Ranbaxy in $4 Billion Deal  La Repubblica1 week ago
[x]  

From a drug distributor to global pharma tycoon

Dilip Shanghvi, born to a Gujarati family in a small town of Gujarat in Amreli in 1955, started Sun Pharmaceutical Industries with capital of Rs 10,000 in 1982 at Vapi. Today, the market cap of the company is more than Rs 1.20 lakh crore, with ...
 DNA India1 week ago DILIP SHANGHVI : From a drug distributor to global pharma tycoon  4 Traders1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - sun pharma advanced research
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less